CS651989A3 - Process for preparing compounds with nootropic effect - Google Patents
Process for preparing compounds with nootropic effectInfo
- Publication number
- CS651989A3 CS651989A3 CS896519A CS651989A CS651989A3 CS 651989 A3 CS651989 A3 CS 651989A3 CS 896519 A CS896519 A CS 896519A CS 651989 A CS651989 A CS 651989A CS 651989 A3 CS651989 A3 CS 651989A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- preparing compounds
- nootropic effect
- nootropic
- effect
- nootropic activity
- Prior art date
Links
- 230000001777 nootropic effect Effects 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Cosmetics (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863610391 DE3610391A1 (de) | 1986-03-27 | 1986-03-27 | Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS276385B6 CS276385B6 (en) | 1992-05-13 |
| CS651989A3 true CS651989A3 (en) | 1992-05-13 |
Family
ID=6297417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS896519A CS651989A3 (en) | 1986-03-27 | 1987-03-27 | Process for preparing compounds with nootropic effect |
| CS872126A CS212687A3 (en) | 1986-03-27 | 1987-03-27 | Process for preparing compounds with nootropic activity |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS872126A CS212687A3 (en) | 1986-03-27 | 1987-03-27 | Process for preparing compounds with nootropic activity |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0243645B1 (cs) |
| JP (1) | JPS62240698A (cs) |
| KR (1) | KR870008841A (cs) |
| CN (1) | CN1031267C (cs) |
| AT (1) | ATE102954T1 (cs) |
| AU (1) | AU621278B2 (cs) |
| CA (1) | CA1341064C (cs) |
| CS (2) | CS651989A3 (cs) |
| DD (1) | DD280765A5 (cs) |
| DE (2) | DE3610391A1 (cs) |
| DK (1) | DK172221B1 (cs) |
| EG (1) | EG18175A (cs) |
| ES (1) | ES2061447T3 (cs) |
| FI (1) | FI91876C (cs) |
| HU (2) | HU202118B (cs) |
| IE (1) | IE62456B1 (cs) |
| MA (1) | MA20919A1 (cs) |
| NO (1) | NO178546C (cs) |
| NZ (1) | NZ219764A (cs) |
| OA (1) | OA08506A (cs) |
| PH (1) | PH27210A (cs) |
| PT (1) | PT84564B (cs) |
| RU (1) | RU1836335C (cs) |
| TN (1) | TNSN87045A1 (cs) |
| ZA (1) | ZA872230B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| CA1321753C (en) * | 1987-04-27 | 1993-08-31 | Abraham Sudilovsky | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
| DE3731085A1 (de) * | 1987-09-16 | 1989-04-06 | Hoechst Ag | Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
| DE3801587A1 (de) * | 1988-01-21 | 1989-08-03 | Hoechst Ag | Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| EP0331609A3 (de) * | 1988-01-27 | 1992-07-01 | Hoechst Aktiengesellschaft | Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung |
| DE3803225A1 (de) * | 1988-02-04 | 1989-08-17 | Hoechst Ag | Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung |
| JPH01275529A (ja) * | 1988-03-21 | 1989-11-06 | E R Squibb & Sons Inc | 晩発性運動障害の抑制治療剤 |
| US5037821A (en) * | 1988-06-01 | 1991-08-06 | E. R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor |
| US5093129A (en) * | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
| US5032578A (en) * | 1990-09-17 | 1991-07-16 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| US20020187977A1 (en) * | 2001-03-15 | 2002-12-12 | Rodney Pearlman | Methods for restoring cognitive function following systemic stress |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3174844D1 (en) * | 1980-10-23 | 1986-07-24 | Schering Corp | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
-
1986
- 1986-03-27 DE DE19863610391 patent/DE3610391A1/de not_active Withdrawn
-
1987
- 1987-03-18 EP EP87103938A patent/EP0243645B1/de not_active Expired - Lifetime
- 1987-03-18 AT AT87103938T patent/ATE102954T1/de not_active IP Right Cessation
- 1987-03-18 DE DE87103938T patent/DE3789330D1/de not_active Expired - Lifetime
- 1987-03-18 ES ES87103938T patent/ES2061447T3/es not_active Expired - Lifetime
- 1987-03-25 NZ NZ219764A patent/NZ219764A/en unknown
- 1987-03-25 MA MA21159A patent/MA20919A1/fr unknown
- 1987-03-25 HU HU896609A patent/HU202118B/hu unknown
- 1987-03-25 DD DD87301118A patent/DD280765A5/de not_active IP Right Cessation
- 1987-03-25 HU HU871308A patent/HU203117B/hu unknown
- 1987-03-25 PH PH35073A patent/PH27210A/en unknown
- 1987-03-25 FI FI871304A patent/FI91876C/fi not_active IP Right Cessation
- 1987-03-25 EG EG18087A patent/EG18175A/xx active
- 1987-03-26 AU AU70649/87A patent/AU621278B2/en not_active Expired
- 1987-03-26 PT PT84564A patent/PT84564B/pt unknown
- 1987-03-26 RU SU874202302A patent/RU1836335C/ru active
- 1987-03-26 CA CA000533092A patent/CA1341064C/en not_active Expired - Lifetime
- 1987-03-26 DK DK153587A patent/DK172221B1/da not_active IP Right Cessation
- 1987-03-26 JP JP62070541A patent/JPS62240698A/ja active Pending
- 1987-03-26 ZA ZA872230A patent/ZA872230B/xx unknown
- 1987-03-26 KR KR870002775A patent/KR870008841A/ko not_active Ceased
- 1987-03-26 IE IE78487A patent/IE62456B1/en not_active IP Right Cessation
- 1987-03-26 NO NO871282A patent/NO178546C/no unknown
- 1987-03-27 CS CS896519A patent/CS651989A3/cs not_active IP Right Cessation
- 1987-03-27 CN CN87102304A patent/CN1031267C/zh not_active Expired - Lifetime
- 1987-03-27 TN TNTNSN87045A patent/TNSN87045A1/fr unknown
- 1987-03-27 OA OA59095A patent/OA08506A/xx unknown
- 1987-03-27 CS CS872126A patent/CS212687A3/cs unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT43582A (en) | Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof | |
| GR860571B (en) | Labdan-derivatives process for their preparation and their use as medicaments | |
| PH31617A (en) | Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds. | |
| CS651989A3 (en) | Process for preparing compounds with nootropic effect | |
| IL89031A0 (en) | Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation | |
| ES8503643A1 (es) | Un procedimiento para la preparacion de compuestos de bis (carboxamida) | |
| EP0229566A3 (en) | 1-benzene sulfonyl 2-oxo-5-alkoxy pyrrolidines, process for their preparation, their use as medicine and compositions containing them | |
| PH24568A (en) | Use of bezafibrate for treating diabetes | |
| GR3005743T3 (cs) | ||
| EP0257631A3 (en) | Oxolabdanes, a process for their preparation and their use as medicaments | |
| ES8203086A1 (es) | Un procedimiento para la produccion de n,n'-bis-(3-picolil) -4-metoxi-isoftalamida monohidratada | |
| GR3002365T3 (en) | Medicines containing as a mixture interferon and 1-desoxy-piperidinoses, process for their manufacture and their use | |
| ZA872677B (en) | Pharmaceutical compositions for the treatment of intermittent claudication | |
| JO1516B1 (en) | Compounds with cognitive effectiveness, factors containing them, and their use in treatment and disease prevention for cognitive dysfunction | |
| HUT41441A (en) | Process for producing antracyclin derivatives and pharmaceutical compositions containing themas active agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MK4A | Patent expired |
Effective date: 20070327 |